Tuberculosis testing and treatment needs to happen close to the point of infection. PBD Biotech has developed a lyophilized PCR reaction bead for its Actiphage ® blood test for active TB. This enables ...

A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 ...

COVID-19 case numbers may be plummeting, but demand for fast-acting and easily accessible PCR-quality diagnostics—for the coronavirus and beyond—shows no sign of slowing down. Ready to meet that ...

Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care diagnostics for timely outbreak detection worldwide. FRANKFURT, Germany, Aug. 8, 2025 ...

Though PCR testing has been established as the gold standard for COVID-19 detection, it remains less accessible than rapid antigen testing, since most PCR tests typically take longer to return results ...

Hello and welcome to this edition of the Biotech bi-weekly, a fortnightly listicle bringing you a rapid review of the latest happenings and developments in the biotech industry! As ever with a new ...

The biophysics company Depixus (Paris, France) has launched a new technology designed to analyze thousands of individual biomolecular interactions simultaneously and in real time. The technology, ...

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp ...